Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
2016 · Autophagy · 5,966 citations
https://doi.org/10.1080/15548627.2015.1100356
P
Peter J. O’Dwyer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
768
Papers
42.1K
Citations
87
h-index
292
i10-index
Peter J. O’Dwyer is an academic researcher from Hospital of the University of Pennsylvania. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Cancer Genomics and Diagnostics & Pancreatic and Hepatic Oncology Research. The author has an h-index of 87, co-authored 653 publications.
ORCID: 0000-0002-9302-4073Papers by this author
worksSorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis
2006 · British Journal of Cancer · 633 citations
https://doi.org/10.1038/sj.bjc.6603291
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients
2015 · Nature Communications · 477 citations
https://doi.org/10.1038/ncomms8686
CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb+ Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment
2014 · Clinical Cancer Research · 341 citations
https://doi.org/10.1158/1078-0432.ccr-14-2258
Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer
2019 · JAMA Oncology · 277 citations
https://doi.org/10.1001/jamaoncol.2019.0684
Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation
2019 · British Journal of Cancer · 195 citations
https://doi.org/10.1038/s41416-019-0582-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat